GALAPAGOS

Serial Number 78810179
Registration 3339468
800

Registration Progress

Application Filed
Feb 8, 2006
Under Examination
Approved for Publication
Aug 15, 2007
Published for Opposition
Sep 4, 2007
Registered
Nov 20, 2007

Basic Information

Serial Number
78810179
Registration Number
3339468
Filing Date
February 8, 2006
Registration Date
November 20, 2007
Published for Opposition
September 4, 2007
Renewal Date
November 20, 2017
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Nov 27, 2017
Registration
Registered
Classes
001 005 042

Rights Holder

Galapagos NV

03
Address
Generaal de Wittelaan, L11 A3
Mechelen B-2800
BE

Ownership History

Galapagos NV

Original Applicant
03
Mechelen BE

Galapagos NV

Owner at Publication
03
Mechelen BE

Galapagos NV

Original Registrant
03
Mechelen BE

Legal Representation

Attorney
Alexandra T. MacKay
USPTO Deadlines 1 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
MAINTENANCE
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-11-20)
R.PRA Nov 20, 2027 866 days Critical No
Next deadline: Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-11-20) on November 20, 2027 (866 days)

Application History

42 events
Date Code Type Description
Nov 27, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 27, 2017 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 27, 2017 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 27, 2017 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Oct 30, 2017 E89R I TEAS SECTION 8 & 9 RECEIVED
Nov 20, 2016 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 24, 2013 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 24, 2013 15AK O REGISTERED - SEC. 15 ACKNOWLEDGED
Jan 24, 2013 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jan 24, 2013 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jan 24, 2013 NA15 E SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Jan 15, 2013 ES8R I TEAS SECTION 8 RECEIVED
Jan 15, 2013 E15R I TEAS SECTION 15 RECEIVED
Jul 13, 2009 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 13, 2009 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 20, 2007 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 4, 2007 PUBO A PUBLISHED FOR OPPOSITION
Aug 15, 2007 NPUB O NOTICE OF PUBLICATION
May 24, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
May 23, 2007 CNEA O EXAMINERS AMENDMENT MAILED
May 22, 2007 CNEA R EXAMINERS AMENDMENT -WRITTEN
May 22, 2007 XAEC I EXAMINER'S AMENDMENT ENTERED
May 22, 2007 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2007 CNFR O FINAL REFUSAL MAILED
Mar 19, 2007 CNFR R FINAL REFUSAL WRITTEN
Feb 27, 2007 ALIE A ASSIGNED TO LIE
Feb 27, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2007 ACEC I AMENDMENT FROM APPLICANT ENTERED
Jan 29, 2007 MAIL I PAPER RECEIVED
Oct 12, 2006 FAXX O FAX SENT
Sep 12, 2006 CNRT O NON-FINAL ACTION MAILED
Sep 11, 2006 CNRT R NON-FINAL ACTION WRITTEN
Sep 8, 2006 UNDN O UNDELIVERABLE MAIL - NO ACTION TAKEN
Aug 16, 2006 ACEC I AMENDMENT FROM APPLICANT ENTERED
Jul 31, 2006 CNRT F NON-FINAL ACTION MAILED
Jul 29, 2006 CNRT R NON-FINAL ACTION WRITTEN
Jul 28, 2006 DOCK D ASSIGNED TO EXAMINER
Jul 20, 2006 UNPR I UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Jul 20, 2006 UNPR I UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Jun 16, 2006 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 5, 2006 MAIL I PAPER RECEIVED
Feb 14, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM

Detailed Classifications

Class 001
Biochemicals for use in the manufacture of pharmaceutical [ and veterinary ] preparations
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
(( Pharmaceuticals and biochemical preparations for the treatment of bone, cartilage and joint diseases, in particular osteoporosis, osteoarthritis and rheumatoid arthritis, and for the treatment of inflammation and immune diseases, proliferative and metastatic diseases, and metabolic diseases ))
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Scientific research services in the medical and biochemical fields, namely, the examination and testing of genes as part of research and discovery procedures; development, examination and testing of pharmaceutical and biochemical semi-finished products, especially for use in medicaments; development, examination and testing of medicaments; development of test systems for pharmaceutical and biochemical products [, veterinary and hygienic products for medical use, and dietetic substances for medical use ]; development of database in the medical and biochemical field and development of genes banks
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001 005 042